The anti-ovarian cancer activity by WYE-132, a mTORC1/2 dual inhibitor.
about
Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor MicroenvironmentVascular endothelial growth factor A as predictive marker for mTOR inhibition in relapsing high-grade serous ovarian cancerRecent advances in targeting mTOR signaling pathway using small molecule inhibitors.Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.Preclinical study of CC223 as a potential anti-ovarian cancer agent.New Insights into mTOR Signal Pathways in Ovarian-Related Diseases: Polycystic Ovary Syndrome and Ovarian CancerPI3K/AKT/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?
P2860
Q28069459-8776AA0E-178B-4CB8-ACF2-E43F9798E858Q35992948-C5B2576B-A82D-4A4E-9A9C-64751851149AQ38955246-1941FDA0-226B-4357-B982-4C10C5071A4FQ39207332-532A1017-6421-44B9-B0C2-9A863D9D6B37Q41709197-4C7F4AFF-2EF5-4D8B-9F2D-45A9D1D02AFAQ42144129-B905C4D1-91C4-47CA-9689-BBC572C96B94Q43300329-A3534403-EB3A-4A23-B490-3681D515CE8F
P2860
The anti-ovarian cancer activity by WYE-132, a mTORC1/2 dual inhibitor.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The anti-ovarian cancer activity by WYE-132, a mTORC1/2 dual inhibitor.
@en
type
label
The anti-ovarian cancer activity by WYE-132, a mTORC1/2 dual inhibitor.
@en
prefLabel
The anti-ovarian cancer activity by WYE-132, a mTORC1/2 dual inhibitor.
@en
P2093
P2860
P1433
P1476
The anti-ovarian cancer activity by WYE-132, a mTORC1/2 dual inhibitor.
@en
P2093
P2860
P2888
P304
P356
10.1007/S13277-015-3922-0
P577
2015-08-21T00:00:00Z
P6179
1052933275